Table 1.
The suppression effects of phlorotannins on sensitizer-induced mouse ear swelling.
Sensitizer | Test Groups | Control | Eckol | 6,6′-Bieckol | 6,8′-Bieckol |
AA | Ear swelling (mm) | 0.193 ± 0.026 | 0.169 ± 0.011 | 0.112 ** ± 0.049 | 0.116 ** ± 0.036 |
Suppression (%) | — | 12.7 ± 5.4 | 41.9 # ± 25.4 | 39.8 # ± 18.7 | |
TPA | Ear swelling (mm) | 0.194 ± 0.038 | 0.116 ** ± 0.009 | 0.174 * ± 0.016 | 0.098 ** ± 0.032 |
Suppression (%) | — | 40.0 # ± 4.5 | 34.2 ± 25.2 | 49.4 * ± 16.4 | |
OXA | Ear swelling (mm) | 0.223 ± 0.024 | 0.180 ± 0.020 | 0.183 ± 0.030 | 0.049 ** ± 0.044 |
Suppression (%) | — | 19.3 ± 9.1 | 17.8 ± 13.5 | 77.8 ** ± 19.7 | |
Sensitizer | Test groups | 8,8′-bieckol | PFF-A | PFF-B | EGCG |
AA | Ear swelling (mm) | 0.153 ± 0.011 | 0.134 * ± 0.021 | 0.112 ** ± 0.030 | 0.168 ± 0.008 |
Suppression (%) | 21.0 ± 5.5 | 30.5 ± 10.6 | 42.2 # ± 15.7 | 12.9 ± 4.2 | |
TPA | Ear swelling (mm) | 0.132 * ± 0.014 | 0.132 * ± 0.007 | 0.119 ** ± 0.031 | 0.167 ± 0.008 |
Suppression (%) | 31.7 ± 7.4 | 31.7 ± 3.8 | 38.4 # ± 16.1 | 13.8 ± 4.4 | |
OXA | Ear swelling (mm) | 0.151 * ± 0.030 | 0.171 ± 0.019 | 0.131 ** ± 0.032 | 0.210 ± 0.001 |
Suppression (%) | 32.3 # ± 13.6 | 23.4 ± 8.6 | 41.0 * ± 14.5 | 5.7 ± 0.1 |
Suppression effects at a dose of 75 nmol/mouse were calculated from the results of quadruplicate experiments (n = 4). Controls were stimulated by sensitizer without phlorotannins. Values are shown as means ± standard deviations. In each sensitizer experiment, the presence of an asterisk in “Ear swelling” indicates that the ear swelling was significantly lower than that of control (*, p < 0.05; **, p < 0.01). An asterisk in “Suppression” indicates that the suppression ratio was significantly higher than that of EGCG (*, p < 0.05; **, p < 0.01), and “#” indicates that it tended to be higher than that of EGCG (0.5 < p < 1.0). Abbreviations: AA, arachidonic acid; TPA, 12-O-tetradecanoylphorbol-13-acetate; OXA, oxazolone; PFF, phlorofucofuroeckol; EGCG, epigallocatechin gallate.